Abbott Laboratories (Pakistan) (KAR:ABOT) Forward Dividend Yield % : 0.00% (As of Jun. 07, 2024)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Forward Dividend Yield %?

As of today (2024-06-07), the Forward Annual Dividend Yield of Abbott Laboratories (Pakistan) is 0.00%.

As of today (2024-06-07), the Trailing Annual Dividend Yield of Abbott Laboratories (Pakistan) is 0.00%.

KAR:ABOT's Forward Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.945
* Ranked among companies with meaningful Forward Dividend Yield % only.

Abbott Laboratories (Pakistan)'s Dividends per Share for the three months ended in Mar. 2024 was ₨0.00.

During the past 12 months, Abbott Laboratories (Pakistan)'s average Dividends Per Share Growth Rate was -100.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Abbott Laboratories (Pakistan) was 78.80% per year. The lowest was -30.70% per year. And the median was 28.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Abbott Laboratories (Pakistan)'s Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories (Pakistan)'s Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s Forward Dividend Yield % falls into.

Abbott Laboratories (Pakistan) Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Abbott Laboratories (Pakistan) (KAR:ABOT) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Abbott Laboratories (Pakistan) Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines